Objective To determine whether brain atrophy and lesion volumes predict subsequent 10
year clinical evolution in multiple sclerosis (MS). Design From eight MAGNIMS (MAGNetic …

Background Patients who have had a stroke with unknown time of onset have been previously
excluded from thrombolysis. We aimed to establish whether intravenous alteplase is safe …

Substitution of lysine 27 to methionine in histone H3 (H3K27M) defines an aggressive
subtype of diffuse glioma. Previous studies have shown that a H3K27M-specific long peptide …

The spinal cord is a clinically important site that is affected by pathological changes in most
patients with multiple sclerosis; however, imaging of the spinal cord with conventional MRI …

Hemorrhagic shock (HS) after tissue trauma increases the complication and mortality rate of
polytrauma (PT) patients. Although several murine trauma models have been introduced, …

H3K27M, a driver mutation with T and B cell neoepitope characteristics, defines an aggressive
subtype of diffuse glioma with poor survival. We functionally dissect the immune response …

Objectives In multiple sclerosis (MS), iron rim lesions (IRLs) are indicators of chronic low-grade
inflammation and ongoing tissue destruction. The aim of this study was to assess the …

Background Several studies have pointed out that seemingly chronic multiple sclerosis (MS)
lesions may also be in inflammatory states. In pathological studies, up to 40% of chronic MS …

Objective To characterize the distribution and regional evolution of cervical cord atrophy in
patients with multiple sclerosis (MS) in a multicenter dataset. Methods MRI and clinical …

Background: Advanced magnetic resonance imaging (MRI) techniques provide a window
into pathological processes in multiple sclerosis (MS). Nevertheless, to date only few studies …